Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
OXYGEN, USP is a respiratory gas product administered via inhalation to treat patients requiring supplemental oxygen therapy. As a foundational therapeutic agent, it is indicated for patients with hypoxemia, respiratory distress, and various pulmonary conditions. Oxygen functions through direct oxygenation of blood and tissues, supporting cellular respiration and metabolic function.
As a peak-stage commodity therapeutic with moderate competitive pressure (30), commercial teams focus on supply chain optimization, hospital contracts, and reimbursement management rather than demand generation.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Safety Study of Intravenous Hydrogen-Oxygen Ultrafine Bubbles in Adults
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
Normobaric Oxygen Therapy in Colorectal Cancer Patients
Worked on OXYGEN, USP at Universal Cells? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on OXYGEN, USP offers stability in a mature, essential-care market with focus on operational excellence, regulatory compliance, and supply chain strategy. Career growth emphasizes business acumen, contract negotiation, and healthcare system navigation rather than product innovation or clinical development.